Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
The Veterinary Quarterly|October 1, 1994
Double blind field evaluation of a trivalent vaccine against respiratory disease in veal calvesK Frankena, C H Klaassen, J C Bosch, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Capture-recapture and anti-tuberculosis drug prescriptions, Balearic Islands, Spain, 2010-2012J Gimenez-Duran, A Galmes-Truyols, T Gonzalez-Cortijo, et al.
British Journal of Cancer|April 29, 2010
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerJ Feliu, M J Safont, A Salud, et al.
European Journal of Cancer Care|January 22, 2013
Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practiceD Almenar Cubells, C Bosch Roig, E Jiménez Orozco, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Systematic isolation of peptide signal molecules regulating development in hydra: LWamide and PW familiesT Takahashi, Y Muneoka, J Lohmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2015
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†C Fernandez-Martos, X Garcia-Albeniz, C Pericay, et al.
IJTLD Open|June 26, 2024
Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South AfricaC Bekker, I Dewandel, A Redfern, et al.
British Journal of Cancer|June 20, 2014
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX studyJ Feliu, A Salud, M J Safont, et al.
Vaccine|June 2, 1998
An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the fieldJ C Bosch, M C De Jong, P Franken, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trialEstela Pineda, A Salud, E Vila-Navarro, et al.
Pageof 30